BayWa AG:企業のM&A・事業提携・投資動向

◆英語タイトル:BayWa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2201
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

BayWa AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s BayWa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BayWa AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes BayWa AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BayWa AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on BayWa AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by BayWa AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for BayWa AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about BayWa AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 36
Corporate Venturing – Overview 36
Corporate Venturing – Deal reports 37
PARTNERSHIP 41
Partnership – Overview 41
Partnership – Deal reports 42
CAPITAL RAISING 49
Capital Raising – Overview 49
Capital Raising – Deal reports 50
DIVESTMENTS 52
Divestments – Overview 52
Divestments – Deal reports 53
APPENDIX 60
Contact Us 60
About MarketLine Financial Deals Database 60
Deal Definition and Methodology 62
About MarketLine 69

List of Tables
Table 1: BayWa AG M&A volume and value trend (2014-YTD2018)
Table 2: BayWa AG M&A activity by geography (2014-YTD2018)
Table 3: BayWa AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: BayWa AG corporate venturing by geography (2014-YTD2018)
Table 5: BayWa AG partnership volume and value trend (2014-YTD2018)
Table 6: BayWa AG partnership trend by key deal type (2014-YTD2018)
Table 7: BayWa AG capital raising volume and value trend (2014-YTD2018)
Table 8: BayWa AG capital raising by deal type (2014-YTD2018)
Table 9: BayWa AG divestments volume and value trend (2014-YTD2018)
Table 10: BayWa AG divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: BayWa AG M&A volume and value trend (2014-YTD2018)
Figure 2: BayWa AG M&A activity by geography (2014-YTD2018)
Figure 3: BayWa AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: BayWa AG corporate venturing by geography (2014-YTD2018)
Figure 5: BayWa AG partnership volume and value trend (2014-YTD2018)
Figure 6: BayWa AG partnership trend by key deal type (2014-YTD2018)
Figure 7: BayWa AG capital raising volume and value trend (2014-YTD2018)
Figure 8: BayWa AG capital raising by deal type (2014-YTD2018)
Figure 9: BayWa AG divestments volume and value trend (2014-YTD2018)
Figure 10: BayWa AG divestments by geography (2014-YTD2018)

★海外企業調査レポート[BayWa AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Kuwait Reinsurance Company K.S.C.C.:企業の戦略・SWOT・財務情報
    Kuwait Reinsurance Company K.S.C.C. - Strategy, SWOT and Corporate Finance Report Summary Kuwait Reinsurance Company K.S.C.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Grupo Industrial Saltillo, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pacific Gas and Electric Co:企業の戦略的SWOT分析
    Pacific Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Curida AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Curida AS (Curida) is a contract development and manufacturing organization that manufactures sterile liquid pharmaceuticals based on unit-dose Blow-Fill-Seal (BFS) technology. It specializes in the development of nasal and inhalation drug products. The company provides laboratory, analytica …
  • Granit AD Skopje:企業の戦略・SWOT・財務情報
    Granit AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Granit AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mari Petroleum Co Ltd (MARI):石油・ガス:M&Aディール及び事業提携情報
    Summary Mari Petroleum Co Ltd (MPCL) is an integrated exploration and production company. It carries out exploration and production of crude oil, natural gas, condensate and liquefied petroleum gas (LPG). The company operates through exploration and production assets across four provinces in Pakista …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • NBT Bancorp Inc:企業の戦略・SWOT・財務情報
    NBT Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary NBT Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Environmental Tectonics Corporation:企業の戦略・SWOT・財務情報
    Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆